• Save €2.20
search

Neoborocillin throat pastilles classic taste 022632121

  • ALFASIGMA SpA
  • 022632121

Neoborocillin throat disinfectant tablets.

- They act quickly.

-Pleasant taste.

info_outline View product sheet
Final Price €6.00
Regular Price €8.20
Save €2.20
Quantity
check_circle Available (12 Items)
48h
  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Other products Others products at unbeatable price

ALFASIGMA SpA

Discover all products

NEOBOROCILLIN * 16PAST 1,2 + 20MG

Therapeutic indications

Antiseptic of the oropharyngeal cavity.

Dosage and method of use

Slowly dissolve one tablet in your mouth every 2-3 hours, up to a maximum of 8 tablets per day. Do not exceed the recommended dose.

Contraindications

Hypersensitivity to the active substances or to any of the excipients. The tablets are contraindicated in children under two years of age, with a predisposition to laryngospasm and convulsions.

Side effects

Very rarely reported: hypersensitivity reactions, spinning sensation, respiratory failure, glottal edema, vomiting, malaise, sweating, arm edema, perioral edema, eyelid edema, face edema, urticaria, haemolytic anemia, jaundice . Sodium benzoate is mildly irritating to the skin and mucous membranes. Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

Special warnings

Due to the presence of menthol, Neo Borocillin tablets are contraindicated in children under two years of age with a predisposition to laryngospasm and convulsions. They must be used with caution, and under direct medical supervision, even in older children. This medicine contains 0.9 g of sucrose (in the form of sucrose and compressible sugar) per - lozenge: to be taken into consideration in people with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. This medicinal product contains 3.2 mg of sodium as the active ingredient per tablet and 25.5 mg of sodium per daily dose equivalent to 1.3% of the WHO recommended maximum daily intake of 2 g of sodium for an adult. The use, especially if prolonged, of products for oral topical use can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and consult the doctor in order to establish any suitable therapy. After a short period of treatment without noticeable results, consult your doctor. KEEP OUT OF THE REACH AND SIGHT OF CHILDREN.

Pregnancy and breastfeeding

There are no adequate data from the use of 2,4-dichlorobenzyl alcohol and sodium benzoate in pregnant women. In pregnant and lactating women, the product should be administered in case of real need and under direct medical supervision.

Expiration and retention

Store at a temperature not exceeding 30 ° C.

Interactions with other drugs

Avoid the simultaneous use of other antiseptics.

Overdose

No cases of overdose have been reported. In the event of an overdose, appropriate symptomatic treatments should be adopted.

Active principles

One tablet contains: Active ingredients - 2,4 DICHLOROBENZIL ALCOOL 1.2 mg - SODIUM BENZOATE 20 mg (equivalent to 17 mg of benzoic acid) Excipients with known effects: - compressible sugar 847.717 mg - sucrose 4.38 mg For the list complete with excipients, see 6.1

Excipients

Compressible sugar , copovidone, magnesium stearate, hydrated colloidal silica, levomentol, sucrose , mint essence, eucalyptol, citral.

ALFASIGMA SpA
022632121
12 Items

Data sheet

Packaging
1.2 mg + 20 mg 16 tablets
Product Type
HUMAN DRUG
ATC code
R02AA03
ATC description
Dichlorobenzyl alcohol
Therapeutic Group
Antiseptics
Active principle
dichlorobenzyl alcohol + sodium benzoate
Class
C.
Pharmaceutical form
tablet
Type of Administration
buccal / mucoadhesive
Container
cpr / cps / pills / confetti in blister packs
Quantity
16 tablet
Quantity of the Active Ingredient
20MG (sodium benzoate) + 1.2MG (dichlorobenzyl alcohol)
Recipe required
OTC - self-medication medicine